Sanofi plans to boost its U.S.-based research and development and manufacturing investments to at least $20 billon over the next five years. In a May 14 press release, the French multinational ...

Sanofi last week closed its purchase of an early-stage immunology drug candidate from Dren Bio for up to $1.9 billion and in May agreed to acquire Vigil Neuroscience for about $470 million, adding ...